Renal amyloidosis in familial Mediterranean fever

Kidney International

Volumn 65, Issue 3, 2004, Pages 1118-1127

  Ozen, Seza ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Henoch Sch nlein purpura; Polyarteritis nodosa; Pyrin; TRAPS; Vasculitis

Indexed keywords

ANTIBIOTIC AGENT; COLCHICINE; CREATININE; PENICILLIN G; PREDNISONE;

ABDOMINAL PAIN; ADOLESCENT; ANAPHYLACTOID PURPURA; ANKLE; ANTIBIOTIC THERAPY; ARTHRALGIA; ARTHRITIS; CASE REPORT; CLINICAL FEATURE; COUGHING; CREATININE BLOOD LEVEL; DIAGNOSTIC ERROR; DIARRHEA; DYSPNEA; FAMILIAL MEDITERRANEAN FEVER; FAMILY HISTORY; FATIGUE; FEVER; GENE MUTATION; HEMODIALYSIS; HOMOZYGOTE; HUMAN; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FUNCTION; KNEE ARTHRITIS; LABORATORY TEST; LOBAR PNEUMONIA; MALE; MUTATIONAL ANALYSIS; NEPHROTIC SYNDROME; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; RASH; REVIEW; RHEUMATIC FEVER; SYMPTOM; THORAX PAIN; TREATMENT FAILURE; VASCULITIS;

EID: 1342302269     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00485.x     Document Type: Review

References (72)

1. INTERNATIONAL FMF CONSORTIUM: Ancient missense mutations in a new member of the RoRet gene family are likely to cause FMF. Cell 90:797-807, 1997
2. LIVNEH A, LANGEVITZ P, ZEMER D, et al: The changing face of FMF. Semin Arthritis Rheum 26:612-627, 1996
3. OZEN S: Vasculopathy, Behcet's syndrome, and familial Meditteranean fever. Curr Opin Rheumatol 11:393-398, 1999
4. BEN-CHETRIT E: FMF and renal AA amyloidosis. Phenotype-genotype correlation, treatment and prognosis. J Nephrol 16:431-434, 2003
5. SAATCI U, OZEN S, OZDEMIR S, et al: FMF in children: Report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619-623, 1997
6. HULL KM, SHOHAM N, CHAE JJ, et al: The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 15:61-69, 2003
7. DRENTH JPH, VAN DER MEER JWM: Hereditary periodic fevers. N Engl J Med 345:1747-1757, 2001
8. GUMUCIO DL, DIAZ A, SCHANER P, et al: Fire and ICE: The role of pyrin domain containing proteins in inflammation and apoptosis. Clin Exp Rheum 20 (Suppl 26):S45-S53, 2002
9. THE FRENCH CONSORTIUM: A candidate gene for FMF. Am J Hum Genet 59:603-612, 1996
10. LIVNEH A, LANGEVITZ P, ZEMER D, et al: Criteria for the diagnosis of FMF. Arthritis Rheum 40:1879-1985, 1997
11. SHINAR Y, LIVNEH A, LANGEVITZ P, et al: Genotype-phenotype assessment of common genotypes among patients with FMF. J Rheumatol 27:1703-1707, 2000
12. SHOHAT M, MAGAL N, SHOHAT T, et al: Phenotype-genotype correlation in FMF: Evidence for an association between M694V and amyloidosis. Eur J Hum Genet 7:287-292, 1999
13. SUNGUR C, SUNGUR A, RUACAN S, et al: Diagnostic value of bone marrow biopsy in patients with renal disease secondary to FMF. Kidney Int 44:834-836, 1993
14. OZEN S, TINAZTEPE K, GUCER S, BAKKALOGLU A: Nephrotic syndrome and arthritis in a 12 year old girl. Am J Kidney Dis 36:220-224, 2000
15. TOUITOU I: The spectrum of FMF mutations. Eur J Hum Genet 9:473-483, 2001
16. SAMUELS J, AKSENTIJEVICH I, TOROSYAN Y, et al: FMF at the Millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 77:268-297, 1998
17. YILMAZ E, OZEN S, BALCI B, et al: Mutation frequency of FMF and evidence of a high carrier rate in the Turkish population. Eur J Hum Genet 9:553-555, 2001
18. AYPAR E, OZEN S, OKUR H, et al: Th1 polarization in FMF. J Rheumatol 30:2011-2013, 2003
19. MAJEED HA, EL-SHANTI H, AL-KHATEEB MS, RABAIHA ZA: Genotype/phenotype correlations in Arab patients with FMF. Semin Arthritis Rheum 31:371-376, 2002
20. AKSENTIJEVICH I, TOROSYAN Y, SAMUELS J, et al: Mutation and haplotype studies of FMF reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Askhenazi Jewish population. Am J Hum Genet 64:949, 1999
21. OZEN S, KARAASLAN Y, OZDEMIR O, et al: Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey. A field study. J Rheumatol 25:2445-2449, 1998
22. GERSHONI-BARUCH R, SHINAWI M, LEAH K, et al: FMF: prevalence, penetrance and genetic drift. Eur J Hum Genet 8:3-7, 2001
23. KOGAN A, SHINAR Y, LIDAR M, et al: Common MEFV mutations among Jewish ethnic groups in Israel. Am J Med Genet 102:272-276, 2001
24. OZEN S: What advantage did the heterozygotes for MEFV mutations have-if any? Clin Exp Rheum 20 (Suppl 26):S69, 2002
25. LA REGINA M, NUCERA G, DIACO M, et al: FMF is no longer a rare disease in Italy. Eur J Hum Genet 11:50-56, 2003
26. SHINOZAKI K, AGEMATSU K, YASUI K, et al: FMF in 2 Japanese families. J Rheumatol 29:1324-1325, 2002
27. BOOTH DR, LACHMANN JH, GILLMORE JD, et al: Prevalence and significance of the FMF gene mutation encoding pyrin Q148. Q J Med 94:527-531, 2001
28. BEN-CHETRIT E, LEVY M: FMF. Lancet 351:659-664, 1998
29. SOHAR E, PRAS M, GAFNI J: FMF and its articular manifestations. Clin Rheum Dis 1:195-209, 1975
30. SOHAR E, GAFNI J, PRAS M, et al: FMF: A survey of 470 cases and review of the literature. Am J Med 43:227-253, 1967
31. YALCINKAYA F, TURNER N: Glomerular lesions other than amyloidosis in patients with FMF. Nephrol Dial Transplant 14:21-23, 1999
32. AKPOLAT T, AKPOLAT I, KARAGOZ F, et al: Familial Mediterranean fever and glomerulonephritis and review of the literature. Rheumatol Int June 27, 2003 (Epub)
33. SAID R, HAMZEH Y, SAID S, et al: Spectrum of renal involvement in FMF. Kidney Int 41:414-419, 1992
34. OZEN S, BEN-CHETRIT E, BAKKALOGLU A, et al: PAN in patients with FMF: A concomitant disease or a feature of FMF? Semin Arthritis Rheum 30:281-287, 2001
35. OZDOGAN H, ARISOY N, KASAPCOPUR O, et al: Vasculitis in FMF. J Rheumatol 24:323-327, 1997
36. MCDERMOTT MF, AKSENTIJEVICH I, GALON J, et al: Germline mutations in the extracellular domains of the 55kDa TNF receptor define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133-144, 1999
37. HOFFMAN HM, MUELLER JL, BROIDE DH, et al: Mutation of a new gene encoding a putative pyrin-like protein causes FCAS and MWS. Nat Genet 29:301-305, 2001
38. FELDMAN J, PRIEUR AM, QUARTIER P, et al: CINCA syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71:198-203, 2002
39. AKSENTIJEVICH I, NOWAK M, MALLAH M, et al: De novo CIAS1 mutations, cytokine activation and evidence for genetic heterogeneity in patients with NOMID. Arthritis Rheum 46:3340-3348, 2002
40. HAWKINS P: Evaluation, significance and treatment of inflammation in the inherited periodic fever syndromes. Clin Exp Rheum 20 (Suppl 26):S66-S67, 2000
41. CAZENEUVE C, AJRAPETYAN H, PAPIN S, et al: Identification of MEFV independent modifying genetic factors for FMF. Am J Hum Genet 67:1136-1143, 2000
42. GERSHONI-BARUCH R, BRIK R, et al: The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with FMF. Arthritis Rheum 48:1149-1155, 2003
43. YILMAZ E, KUTLAY S, OZEN S, et al: SAA1 polymorphism is a predictor for amyloid development in familial Mediterranean fever. Turk J Ped 45:198-202, 2003
44. OZER FL, KAPLAMAN E, ZILELI S: FMF in Turkey. Am J Med 50:336-339, 1971
45. CAKAR N, YALCINKAYA F, OZKAYA N, et al: FMF associated amyloidosis in childhood. Clinical features, course and outcome. Clin Exp Rheumatol 19:S63-S67, 2001
46. AKAR E, YALCINKAYA F, AKAR N: Is the A138G alteration of MEFV gene important for amyloidosis? Hum Mutat 17:71, 2001
47. SCHWABE AD, PETERS RS: FMF in Armenians. Analysis of 100 cases. Medicine 53:453-462, 1974
48. ZEMER D, LIVNEH A, DANON YI, et al: Long term colchicine treatment in children with FMF. Arthritis Rheum 34:973-977, 1991
49. ONER A, ERDOGAN O, DEMIRCIN G, et al: Efficacy of colchicine therapy in amyloid nephropathy of FMF. Pediatr Nephrol 18:521-526, 2003
50. DRENTH JP, CUISSET L, GRATEAU G, et al: Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 22:178-181, 1999
51. HOUTEN SM, KUIS W, DURAN M, et al: Mutations in MVK encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 22:175-177, 1999
52. HOFFMAN HM, MUELLER JL, BROIDE DH, et al: Mutation of a new gene encoding a putative pyrin-like protein causes FCAS and MWS. Nat Genet 29:301-305, 2001
53. TUGLULAR S, YALCINKAYA F, PAYDAS S, et al: A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 17:2003-2005, 2002
54. SHABTAI M, BEN-HAIM M, ZEMER D, et al: Detrimental effects of cyclosporin A on long term graft survival in FF renal allograft recipients. Isr Med Assoc J 4:935-939, 2002
55. LIVNEH A, ZEMER D, SIEGAL B, et al: Colchicine prevents kidney transplant amyloidosis in FMF. Nephron 60:418-422, 1992
56. SEVER MS, TURKMEN S, SAHIN A, et al: Renal transplantation in amyloidosis secondary to FMF. Transplant Proc 33:3392-3393, 2001
57. SHERIF AM, REFAIE AF, SOBH MA, et al: Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis 42:370-375, 2003
58. SRINIVASULA SM, POYET J-L, RAZMARA M, et al: The PYRIN CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 277:21119-2122, 2002
59. BAYKAL Y, SAGLAM K, YILMAZ MI, et al: Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99-101, 2003
60. AKAR N, HASIPEK M, AKAR E, et al: Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid 10(1):12-16, 2003
61. SOBH M, REFAIE A, MOUSTAFA F, et al: Study of live donor kidney transplantation outcome in recipients with renal amyloidosis. Nephrol Dial Transplant 9:704-708, 1994
62. OZEN S: FMF: Revisiting an ancient disease. Eur J Pediatr 162:449-454, 2003
63. BAKKALOGLU A: Familial Mediterranean fever. Pediatr Nephrol 18:853-859, 2003
64. DUZOVA A, BAKKALOGLU A, BESBAS N, et al: Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21:509-514, 2003
65. ALTIPARMAK MR, PAMUK ON, PAMUK GE, et al: Colchicine neuromyopathy: a report of six cases. Clin Exp Rheumatol 20:S13-S16, 2002
66. BEN-CHETRIT E, LEVY M: Reproductive system in FMF: An overview. Ann Rheum Dis 62:916-919, 2003
67. BEN-CHETRIT E, LEVY M: Colchicine: 1998 update. Semin Arthritis Rheum 28:48-59, 1998
68. TUNCA M, TANKURT E, AKBAYLAR AKPINAR H, et al: The efficacy of interferon alpha on colchicine-resistant FMF attacks: A pilot study. Br J Rheumatol 36:1005-1008, 1997
69. MILLEDGE J, SHAW PJ, MANSOUR A, et al: Allogeneic bone marrow transplantation: Cure for FMF. Blood 100:774-777, 2002
70. SHTRASBOURG S, PRAS M, GAL R, SALAI M, LIVNEH A: Inhibition of the second phase of amyloidogenesis in a mouse model by a single dose colchicine regimen. J Lab Clin Med 138:107-111, 2001
71. BONNEL RA, VILLALBA ML, KARWOSKI CB, BEITZ J: Deaths associated with inappropriate intravenous colchicine administration. J Emerg Med 22:385-387, 2002
72. MAES BD, DALLE I, GEBOES K, et al: Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea. Transplantation 75:665-672, 2003